Skip to main content
Affluent Medical logo

Affluent Medical — Investor Relations & Filings

Ticker · AFME ISIN · FR0013333077 LEI · 969500N30CO4B5N2GN67 PA Manufacturing
Open in API
Filings indexed 275 across all filing types
Latest filing 2025-03-11 Board/Management Inform…
Country FR France
Listing PA AFME

About Affluent Medical

https://www.affluentmedical.com

Affluent Medical is a clinical-stage medical technology company that develops innovative, minimally invasive implants designed to restore essential physiological functions. The company's activities are concentrated in two primary therapeutic areas: structural heart disease and urology. It specifically addresses severe mitral valve insufficiency and urinary incontinence. The product pipeline, currently in clinical development, features three key devices: Kalios™, an adjustable annuloplasty ring for mitral valve repair; Epygon™, a biomimetic mitral valve for replacement procedures; and Artus™, an electronic artificial urinary sphincter for treating urinary incontinence. Affluent Medical's technologies are engineered to be adjustable and biomimetic, allowing for implantation via minimally invasive surgery and adaptation to both the patient's anatomy and the progression of their pathology.

Recent filings

Filing Released Lang Actions
Affluent Medical annonce plusieurs nominations clés aux affaires médicales et cliniques.
Board/Management Information Classification · 98% confidence The document is a press release dated March 11, 2025, announcing three key management appointments (Chief Medical Officers and Director of Clinical Operations) within Affluent Medical. This content directly relates to changes in senior management personnel. According to the definitions, announcements of changes in the company's board of directors or senior management correspond to the 'Board/Management Information' category (MANG). It is not an earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns internal personnel strategy.
2025-03-11 French
Affluent Medical announces several key appointments for Medical and Clinical affairs.
Board/Management Information Classification · 99% confidence The document is a short news release dated March 11, 2025, announcing key leadership appointments (Chief Medical Officers and Director of Clinical Operations) for Affluent Medical. It details the new hires and provides background on the company's product pipeline (KALIOS, EPYGON, ARTUS). This type of announcement, focusing specifically on changes in senior management/board personnel, directly matches the definition for Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Since it is a specific announcement about management changes, MANG is the most appropriate classification over the general Regulatory Filings (RNS). The document length is moderate (under 10,000 characters) and it is the primary content, not an announcement *of* a report.
2025-03-11 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 28.02.25
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short filing (3595 characters) from a French company (Affluent Medical) reporting the 'Nombre d'actions composant le capital social et nombre total de droits de vote' (Number of shares comprising the share capital and total number of voting rights) as of a specific date (28/02/2025). This information is mandated by French commercial code (Article L. 233-8 II) and AMF regulations (Article 223-16). This type of mandatory periodic disclosure regarding share capital structure and voting rights is a specific regulatory filing. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since it is a specific regulatory disclosure about share capital structure, it fits best under the general 'Regulatory Filings' (RNS) category, as there is no specific code for 'Share Capital Disclosure' outside of general capital change announcements (SHA) or insider dealing (DIRS). Given the context of mandatory periodic reporting of voting rights, RNS is the most appropriate general regulatory fallback, although it is a very specific type of disclosure. However, looking closely at the definitions, 'SHA' (Share Issue/Capital Change) might be considered, but this document is a *reporting* of the current state, not an *announcement* of a change/issue. Therefore, RNS (Regulatory Filings) is the safest classification for this mandatory periodic disclosure.
2025-03-06 French
Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors
Board/Management Information Classification · 100% confidence The document is a corporate news release dated February 25, 2025, announcing that Affluent Medical has appointed Liane Teplitsky as a new member of its Board of Directors. This action directly relates to changes in the company's governing body. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is a direct announcement of a board change, not a general regulatory filing or a report itself.
2025-02-26 English
Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors.
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new member to the Board of Directors, Liane Teplitsky. This type of announcement, detailing changes in senior management or the board, directly corresponds to the definition of 'Board/Management Information' (MANG). It is not an Annual Report (10-K), Earnings Release (ER), or a comprehensive Interim Report (IR). It is a specific corporate governance/personnel announcement.
2025-02-25 English
Affluent Medical nomme Liane Teplitsky à son Conseil d’administration, une experte reconnue dans le secteur des dispositifs médicaux.
Board/Management Information Classification · 100% confidence The document is a press release dated February 25, 2025, announcing the co-option of Liane Teplitsky to the Board of Directors of Affluent Medical. This announcement concerns a change in the composition of the company's governing body (Board of Directors). According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is clearly an announcement of a board change, not a full financial report (10-K, IR) or a proxy statement (DEF 14A).
2025-02-25 French

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.